IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹471 Cr | ₹884 Cr | ₹1,140 Cr | ₹606 Cr | ₹446 Cr |
What is the latest Consolidated Net Profit of IPCA LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹471 Cr |
Mar2023 | ₹884 Cr |
Mar2022 | ₹1,140 Cr |
Mar2021 | ₹606 Cr |
Mar2020 | ₹446 Cr |
How is Consolidated Net Profit of IPCA LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹471 Cr | -46.69 | |
Mar2023 | ₹884 Cr | -22.45 | |
Mar2022 | ₹1,140 Cr | 88.02 | |
Mar2021 | ₹606 Cr | 36.07 | |
Mar2020 | ₹446 Cr | - |
Compare Consolidated Net Profit of peers of IPCA LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IPCA LABORATORIES | ₹35,521.8 Cr | -6.4% | 0.8% | 10% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,125.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,358.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,957.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,087.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,197.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
IPCA LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IPCA LABORATORIES | -6.4% |
0.8% |
10% |
SENSEX | -1% |
0.3% |
7.4% |
You may also like the below Video Courses